BioSpace News Archive

Press Releases

Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy

October 6, 2025
·
12 min read
Press Releases

European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency

October 6, 2025
·
11 min read
Press Releases

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies

October 6, 2025
·
7 min read
Press Releases

Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025

October 6, 2025
·
4 min read
Press Releases

Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

October 6, 2025
·
11 min read
Press Releases

Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors

October 6, 2025
·
6 min read
Press Releases

Kraig Biocraft Laboratories Announces Production Expansion

October 6, 2025
·
3 min read
Press Releases

Chiesi Group and Arbor Biotechnologies Announce a Global Strategic Partnership to Develop Novel Rare Disease Gene Editing Programs

October 6, 2025
·
7 min read
Press Releases

Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025

October 6, 2025
·
8 min read
Press Releases

Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study

October 6, 2025
·
7 min read